Osipo C - Search Results

1

Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1.

Shah D, Wyatt D, Baker AT, Simms P, Peiffer DS, Fernandez M, Rakha E, Green A, Filipovic A, Miele L, Osipo C. Shah D, et al. Among authors: osipo c. Clin Cancer Res. 2018 Sep 15;24(18):4566-4578. doi: 10.1158/1078-0432.CCR-17-1952. Epub 2018 Jun 12. Clin Cancer Res. 2018. PMID: 29895705 Free PMC article.

2

MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis.

Levenson AS, Thurn KE, Simons LA, Veliceasa D, Jarrett J, Osipo C, Jordan VC, Volpert OV, Satcher RL Jr, Gartenhaus RB. Levenson AS, et al. Among authors: osipo c. Cancer Res. 2005 Dec 1;65(23):10651-6. doi: 10.1158/0008-5472.CAN-05-0845. Cancer Res. 2005. PMID: 16322206

3

Hedgehog signaling in hepatocellular carcinoma: novel therapeutic strategy targeting hedgehog signaling in HCC.

Osipo C, Miele L. Osipo C, et al. Cancer Biol Ther. 2006 Feb;5(2):238-9. doi: 10.4161/cbt.5.2.2566. Epub 2006 Feb 7. Cancer Biol Ther. 2006. PMID: 16552173 Free article. No abstract available.

4

Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.

O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MA, Grigg R, Jordan VC. O'Regan RM, et al. Among authors: osipo c. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2255-63. doi: 10.1158/1078-0432.CCR-05-2584. Clin Cancer Res. 2006. PMID: 16609042

5

Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.

Osipo C, Meeke K, Cheng D, Weichel A, Bertucci A, Liu H, Jordan VC. Osipo C, et al. Int J Oncol. 2007 Feb;30(2):509-20. Int J Oncol. 2007. PMID: 17203234

6

Off the beaten pathway: the complex cross talk between Notch and NF-kappaB.

Osipo C, Golde TE, Osborne BA, Miele LA. Osipo C, et al. Lab Invest. 2008 Jan;88(1):11-7. doi: 10.1038/labinvest.3700700. Epub 2007 Dec 3. Lab Invest. 2008. PMID: 18059366 Free article.

7

ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.

Osipo C, Patel P, Rizzo P, Clementz AG, Hao L, Golde TE, Miele L. Osipo C, et al. Oncogene. 2008 Aug 28;27(37):5019-32. doi: 10.1038/onc.2008.149. Epub 2008 May 12. Oncogene. 2008. PMID: 18469855

8

Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.

Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L. Rizzo P, et al. Among authors: osipo c. Cancer Res. 2008 Jul 1;68(13):5226-35. doi: 10.1158/0008-5472.CAN-07-5744. Cancer Res. 2008. PMID: 18593923 Free PMC article.

9

Rational targeting of Notch signaling in cancer.

Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rizzo P, et al. Among authors: osipo c. Oncogene. 2008 Sep 1;27(38):5124-31. doi: 10.1038/onc.2008.226. Oncogene. 2008. PMID: 18758481 Review.

10

Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer.

Rizzo P, Osipo C, Pannuti A, Golde T, Osborne B, Miele L. Rizzo P, et al. Among authors: osipo c. Adv Enzyme Regul. 2009;49(1):134-41. doi: 10.1016/j.advenzreg.2009.01.008. Epub 2009 Jan 20. Adv Enzyme Regul. 2009. PMID: 19344631 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters